Skip to main content
Log in

Risk factors of hepatitis C virus infection in patients on hemodialysis: A multivariate analysis based on a dialysis register in Central Italy

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

A seroprevalence survey of antibodies to HCV was carried out among 2788 hemodialysis (HD) patients in a region of central Italy. Anti- HCV seroprevalence was 28.6%. A multivariate analysis of risk factors showed a significant association with time on HD, history of blood transfusion and metropolitan area of residence. Our study clearly showed that HCV infection is common among HD patients and is partially associated with preventable factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Natov SN, Pereira BJG. Hepatitis C infection in patients on dialysis. Seminars Dial 1994; 7: 360–368.

    Google Scholar 

  2. Doebbeling BN, Wenzel RP. Nosocomial viral hepatitis and infections transmitted by blood and blood products. In: Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 1995; 2616–2632.

    Google Scholar 

  3. Petrosillo N, Puro V, Ippolito G. Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients. Nephron 1993; 64: 636–639.

    Google Scholar 

  4. Roth D. Hepatitis C virus: The nephrologist's view. Am J Kidney Dis 1995; 25: 3–16.

    Google Scholar 

  5. Moyer LA, Alter NJ. Hepatitis C Virus in the hemodialysis setting: A review with recommendations for control. Seminars Dial 1994; 2: 124–127.

    Google Scholar 

  6. Dussol B, Berthzene P, Brunet P, et al. Hepatitis C Virus infection among chronic dialysis patients in the Southeast of France. Provence-Alpes Cote d'Azour. Nephrol Dial Transplant 1995; 10: 477–478.

    Google Scholar 

  7. Cendoroglo Neto M, Draibe SA, Silva AE, et al. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among hemodialysis and CAPD patients: Evidence for environmental transmission. Nephrol Dial Transplant 1995; 10: 240–246.

    Google Scholar 

  8. Hayashi J, Nakashima K, Kajiyama W, et al. Prevalence of antibody to hepatitis C in hemodialysis patients. Am J Epidemiol 1991; 134: 651–657.

    Google Scholar 

  9. Fabrizi F, Marcelli D, Bacchini G, et al. Antibodies to HCV in chronic renal failure patients on conservative therapy: Prevalence, risk factors and relationship to liver disease. Nephrol Dial Transplant 1994; 9: 780–784.

    Google Scholar 

  10. EGRET Statistical Package. Seattle, Washington: Statistics and Epidemiology Research Corp and Cytel Software Corp; 1991.

  11. Simon N, Courouc AM, Lemarrec N, et al. A twelve year natural history of hepatitis C infection in hemodialysis patients. Kidney Int 1994; 46: 504–511.

    Google Scholar 

  12. Alter MJ. The detection, transmission, and outcome of hepatitis C virus infection. Infect Agents Dis 1993; 2: 155–166.

    Google Scholar 

  13. Allander T, Medin C, Jacobson SH, et al. Hepatitis C transmission in a hemodialysis unit: Molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994; 43: 415–419.

    Google Scholar 

  14. Allander T, Gruber A, Naghavi M, et al. Frequent patient-to-patient transmission of hepatitis C virus in a hematology ward. Lancet 1995; 354: 603–607.

    Google Scholar 

  15. Petrosillo N, Puro V, Jagger J, et al. The risk of occupational exposure and infection by human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in the dialysis setting. Am J Infect Control 1995; 23: 278–285.

    Google Scholar 

  16. Albano A, Pianetti A, Biffi MR, et al. Prevalence of anti-HCV in subjects of various age groups. Eur J Epidemiol 1992; 8: 309–311.

    Google Scholar 

  17. Donahue JG, Munoz A, Ness P, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369–373.

    Google Scholar 

  18. Port FK. End-stage renal disease: Magnitude of the problem, prognosis of future trends and possible solutions. Kidney Int 1995; (Suppl 50): S3-S6.

  19. Di Nardo V, Bonaventura ME, Chiaretti B, Petrosillo N, Puro V, Ippolito G. Low risk of HCV infection in health care workers [letter]. Infection 1994; 22: 115.

    Google Scholar 

  20. Lee SR, Wood CL, Lane MJ, et al. Increased detection of hepatitis C virus infection in commercial plasma donors by a third-generation screening assay. Transfusion 1995; 35: 845–849.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lallo, D.D., Miceli, M., Petrosillo, N. et al. Risk factors of hepatitis C virus infection in patients on hemodialysis: A multivariate analysis based on a dialysis register in Central Italy. Eur J Epidemiol 15, 11–14 (1999). https://doi.org/10.1023/A:1007592912010

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007592912010

Navigation